MARKET

LPCN

LPCN

Lipocine Inc
NASDAQ
2.070
+0.020
+0.98%
Closed 19:30 10/05 EDT
OPEN
2.070
PREV CLOSE
2.050
HIGH
2.135
LOW
2.070
VOLUME
19.76K
TURNOVER
0
52 WEEK HIGH
12.37
52 WEEK LOW
1.810
MARKET CAP
17.07M
P/E (TTM)
-1.1096
1D
5D
1M
3M
1Y
5Y
1D
Monday 10/5 Insider Buying Report: LPCN, CSWC
NASDAQ · 15h ago
Weekly Report: what happened at LPCN last week (0928-1002)?
Weekly Report · 23h ago
Insiders Pile Into Lipocine, Prothena, Pampa, AFC Gamma, ASP
TipRanks · 2d ago
Weekly Report: what happened at LPCN last week (0921-0925)?
Weekly Report · 09/28 09:52
Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock?
NASDAQ · 09/23 16:00
Lipocine Price Target Announced at $4.00/Share by HC Wainwright & Co.
Dow Jones · 09/21 16:46
HC Wainwright & Co. Reiterates Neutral on Lipocine, Announces $4 Price Target
Benzinga · 09/21 16:36
Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Lipocine (LPCN)
TipRanks · 09/21 16:10
More
About LPCN
Lipocine Inc. is a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral delivery of therapeutics. The Company’s clinical development candidates include: LPCN 1154, oral brexanolone, for the treatment of postpartum depression, LPCN 2101, for the treatment of epilepsy, LPCN 2203, an oral candidate targeted for the management of essential tremor, LPCN 2401, an oral proprietary anabolic androgen receptor agonist for improved body composition in obesity management, and LPCN 1148, for the management of decompensated cirrhosis. It is also developing LPCN 1107, for the prevention of preterm birth, LPCN 1154, for rapid relief of postpartum depression, and LPCN 1144, for the treatment of metabolic dysfunction-associated steatohepatitis. Its product candidate, TLANDO, is a novel oral prodrug of testosterone containing testosterone undecanoate developed by the Company.

Webull offers Lipocine Inc stock information, including NASDAQ: LPCN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LPCN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LPCN stock methods without spending real money on the virtual paper trading platform.